Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Helius Medical Technologies Inc
(NQ:
HSDT
)
1.240
-0.040 (-3.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Helius Medical Technologies Inc
< Previous
1
2
3
Next >
Helius Medical Technologies Announces Reverse Stock Split
August 16, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial Results
August 10, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Announces Participation of Montefiore Medical Center in its PoNS® Therapeutic Experience Program
August 07, 2023
Sixth Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’ adherence to PoNS Therapy™ for gait improvement in...
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. to Release Second Quarter 2023 Financial Results on August 10, 2023
August 02, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South Carolina
July 27, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies Announces DMEPOS Accreditation for PoNS
June 20, 2023
-- Critical initial step toward US reimbursement --
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest
June 14, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius to Highlight Innovative PoNS Therapy™ at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS Day
May 24, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial Results
May 11, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023
May 04, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685
April 17, 2023
MS, Stroke and mmTBI Cover Broader Set of Indications Across North American Markets
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary
March 23, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) Device
March 22, 2023
From
Helius Medical Technologies, Inc.; HealthTech Connex Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
March 09, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms from Stroke
March 09, 2023
-- PoNS already approved in Canada for treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury (TBI) and gait deficit due to mild and moderate symptoms from Multiple...
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023
March 06, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies to Present at the 35th Annual ROTH Conference
March 02, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association’s 2023 Combined Sections Meeting
February 15, 2023
Physical therapists in attendance can enhance their skillset with free on-site PoNS training
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022
January 23, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023
January 19, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience Program
January 10, 2023
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple Sclerosis
January 05, 2023
PTAP Lowers the Cost of PoNS Therapy™ for Qualified Americans
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to Walk
January 03, 2023
New Partnership with UpScript Provides Access to Care, Delivers PoNS Devices to Doorsteps
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
December 30, 2022
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results
November 14, 2022
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience Program
November 09, 2022
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience Program
November 08, 2022
-- Third Center of Excellence added in multi-center, company-sponsored, open label observational interventional trial to evaluate the impact of subjects’ adherence to PoNS® therapy for gait improvement...
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius to Showcase Innovative PoNS Device at ACRM’s 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their Gait
November 03, 2022
Physical Therapists Who Visit Booth 512 Can Sign Up for Free Online PoNS Therapy™ Training
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
Helius Medical Technologies, Inc. to Release Third Quarter 2022 Financial Results on November 14, 2022
November 01, 2022
From
Helius Medical Technologies, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.